CRO Oversight for Pharma and Medical Device Sponsors

Every CRO, held to the plan you bought.

The Strategic Client Advocate model, the metrics senior leadership sees, and one governed path from SOW to data lock.

Schedule a CRO Oversight Call Back to Clinical TrialRx

For Pharma and Medical Device Sponsors · CRO Oversight

Your CROs, working your way. Not the other way around.

The Strategic Client Advocate model sits on your side of the table and holds every CRO and vendor to the plan you bought.

The metrics senior leadership sees

Right the First Time

98%fewer SOW and UAT set-up errors

Measured by% of SOW and UAT set-ups flawless

On-Time

38 daysdatabase locks ahead of schedule, on average

Measured bySite activation, enrollment, and first patient inSite visits to completed visit reports uploadedDays interim and final data sets and database locks land against schedule

On-Target

97%of studies closed within approved budget

Measured by% of studies within budget

Voice of the Client

78%rise in Voice-of-Client ratings

Measured by% increase in approval ratings

Dashboard metrics reach the sponsor in real time at every Stage-Gate review.
Start-up metrics from the day of award: study team assembled, award briefing, expectations meeting, kickoff planned versus actual, schedule baselined, contract executed, and study plans signed off.

Set the standard

Your expectations written into the SOW and KPIs

Govern

Stage-Gate reviews and a weekly cadence

Measure

Metrics on units billed versus work completed, data, and budget

Correct

Early escalation, before it becomes a rescue

300+global protocols and 900 projects under the CRO accountability model

1stFSP architect at a sponsor: governance model built and CRO vendors selected

1 sideOn any single study, the principal works for one side only, disclosed at engagement

Data delivered, budget held, change orders down.

Schedule a CRO Oversight Call Back to Clinical TrialRx

The Client Delight Framework

Why sponsors say NO. How it becomes YES.

Seven pains, ranked by sponsors, in every phase of clinical trials, Phase I to IV, and in RWE/RWD studies. Every engagement finds the ones present and removes them, because a rescue that does not fix why trust broke will break again.

Chess pieces set for play down a boardroom table, the chairs and the head seat in view, representing strategy at the executive level

The NO · Seven pains, rankedSatisfied today

1Price / CostExcessive change orders48%
2StrategyScientific, operational, and organizational gaps51%
3RelationshipsPoor partnership58%
4RetentionNo personnel plan33%
5CommunicationNo critical communication plan58%
6AccountabilityNo clear owner29%
7Executive KnowledgeGaps at the executive leadership level48%

The YES

Six disciplines. One promise kept.

TrustControl · Visibility · Communication · Quality

Kickoff and site activationSOW, UAT, and EDC deliverySite managementData lock and audit readinessBudget managementRisk analysis and budget review

Right the First TimeEfficiency and compliance On-TimeSuperior delivery On-TargetBudget held, better decisions

Client Delight + Value + Trust = YES

$1.18BRWE bid opportunity lost in 19 months at one global provider (the principal's win-loss analysis)

69%of sponsors got a "B" team despite "A" team promises

70%worry team disruptions will stretch timelines

Satisfaction: Avoca Group, 2019 data (n = 85 to 93) · Worldwide Clinical Trials sponsor survey, 2024 (n = 140) · Ranking and mapping: the principal's Client Delight framework

Right the First Time · 5-Stage-Gate Review System

One path from SOW to data lock. Every study, every month.

SOW

Pre-award

SOW and Bid

Protocol and SOW reviewed before the price is set

G1·G2

Award · KOM + 4 wks

Strategy and Plan

Team, scope, and schedule baselined

First patient − 4 wks

Readiness

Sites, training, and risk log ready

25% · 75% · last patient

Enrollment Checks

Reviews at every enrollment milestone

G4n

Data lock − 3 months

Lock Readiness

Data cleaned and queries closed early

eTMF final − 4 wks

Close-Out

Audit-ready file and lessons learned

Weekly internal core teamWeekly client meetingWeekly budget review with financeMonthly review with leadership

Questions Executives Ask

Straight answers, before the first call.

What is the Strategic Client Advocate model?

A sponsor-side oversight role that holds every CRO and vendor to the plan you bought. On any single study, the principal works for one side only, disclosed at engagement, so the advice is never split between sponsor and CRO interests.

Which metrics does senior leadership see?

Right the First Time (flawless SOW and UAT set-ups), On-Time (site activation, enrollment, first patient in, and database locks against schedule), On-Target (studies closed within approved budget), and Voice of the Client ratings. Dashboard metrics reach the sponsor in real time at every Stage-Gate review.

How does CRO oversight reduce change orders?

The protocol and SOW are reviewed before the price is set, so scoping misses are caught before award. The change orders that remain are true sponsor-driven scope changes: documented, priced, and approved promptly. In prior roles, 73% of inherited change orders on rescue studies traced back to CRO scoping errors.

Is the work done remotely?

Yes. Delivery runs remotely with global remote teams, and the principal is on site whenever the engagement calls for it.

Engage Clinical TrialRx

Your trial is off-course.
We put it back on target.

Start with a no-obligation rescue assessment. We will diagnose where your program has drifted, map the Voice of the Client (VOC) and Seven Pains failure points actively dragging it, and show you a governed path to recovery in 30 minutes.

Start a Rescue Assessment Email Leadership Directly

Headquarters

2 East Main Street
Pittsboro, IN 46167

Remote delivery worldwide · on site when needed

Office

+1 (317) 799-0212

Direct: +1 (317) 491-2150

Leadership

drc@clinicaltrialrx.com